Germline Mutations and the Impact on NSCLC Patients

Germline Mutations and the Impact on NSCLC Patients
Don Photo

Don
3 years 94 Views
Category:
Description:
Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope addresses on germline mutations and the impact they have on non-small cell lung cancer (NSCLC) patients.